Mesothelioma Keytruda Australia, Novel Systemic Therapy Against Malignant Pleural Mesothelioma Mancuso Translational Lung Cancer Research

Hi all the last time i put an entry into my blog was a few weeks ago so much has happened since then.

Drawing pictures for colouring hard. The mesothelioma community has kept a close eye on immunotherapy as reports from across the globe have shown the latest approach to treating this aggressive cancer to be positive. The protein is used by cancer cells to trick a patients t cells a type of white. In between doses 7 and 8 we went to tasmania for a few days of retreatrelaxation touring and reconnecting with good friends.

Keytruda a newer treatment for both mesothelioma and nsclc. Keytruda mesothelioma australia wonder drug. The drug works by blocking the pd l1 protein which is a protein that can be found on normal and cancer cells.

How keytruda treats mesothelioma. With good news to report the immunotherapy drug keytruda is fast becoming a very talked about drug and is starting to show very promising results over time when used for mesothelioma and 19 other rare cancers. Hi it has taken a few days to get my facts correct with keytruda in australia for mesothelioma asbestos cancer.

Pembrolizumab marketed as keytruda and manufactured by merck co is one of the most well known immunotherapy drugs on the market. Keytruda is an immunotherapy drug categorized as an immune checkpoint inhibitor a type of monoclonal antibody. Keytruda pembrolizumab is a new drug that fights cancer and is increasingly gaining attention for treating both mesothelioma and non small cell lung cancer in addition to melanoma skin cancer.

Italian doctors are reporting an impressive clinical response in a recently published keytruda case study. Last week we reported on mavis nye of england who claims remission from pleural mesothelioma after two years on keytruda an immunotherapy drug. The case is encouraging news for people with advanced malignant mesothelioma.

However this has been met with some resistance due to the relative newness of the treatment the small size of the keynote 28 clinical trial and the fact that clinical studies are still ongoing in australia. Today lou shares her story of how the drug keytruda is helping her in her fight against mesothelioma and how she is campaigning to get this important treatment fast tracked on the australian pbs pharmaceutical benefits scheme in an effort to make it more readily available to mesothelioma patients in her country. The mesothelioma cancer alliance would like to welcome lou williams to our blog.

The case involves a 45 year old woman with metastatic pleural mesotheliomadoctors found cancer in her chest brain and abdomen. If a mesothelioma sufferer is entitled to common law damages a claim is made for the cost of keytruda treatment.